EIB Finances Jennewein Biotechnologie

October, 2018

The European Investment Bank (EIB) announced in late July that it will provide EUR 15 million in financing to Jennewein Biotechnologie GmbH.

The German company has developed breakthrough technology for producing rare functional sugars with a wide range of applications, including nutritional, pharmaceutical and cosmetic products, and is a leading manufacturer of human milk oligosaccharides (HMOs), a key element in human breast milk.

The loan is backed by a guarantee from the European Fund for Strategic Investments (EFSI), part of the EU plan to boost the competitiveness of the European economy.

Jennewein, headquartered in Rheinbreitbach (Rhineland-Palatinate), will reportedly use the funds to upscale its production capacity and build a new R&D center to aid in efforts to expand its HMO product portfolio.